Skip to content
ScienceBlog.com
  • Featured Blogs
    • EU Horizon Blog
    • ESA Tracker
    • Experimental Frontiers
    • Josh Mitteldorf’s Aging Matters
    • Dr. Lu Zhang’s Gondwanaland
    • NeuroEdge
    • NIAAA
    • SciChi
    • The Poetry of Science
    • Wild Science
  • Topics
    • Brain & Behavior
    • Earth, Energy & Environment
    • Health
    • Life & Non-humans
    • Physics & Mathematics
    • Space
    • Technology
  • Our Substack
  • Follow Us!
    • Bluesky
    • Threads
    • FaceBook
    • Google News
    • Twitter/X
  • Contribute/Contact

scientific fraud

In June 2024, a groundbreaking Alzheimer's research paper was retracted over fraud allegations. Did this mean billions of dollars and countless hours of research were wasted? Maybe not. Today, two promising drugs targeting amyloid beta, the focus of the paper, are available. This video explains the amyloid-beta hypothesis, the fraud, and what’s next.

Retracted Alzheimer’s Paper Reshapes Research Landscape, but Progress Continues

Categories Brain & Behavior, Social Sciences

Comments

  • ScienceBlog.com on Scientists Capture For First Time Mind-Bending Einstein Effect
  • Mike on Scientists Capture For First Time Mind-Bending Einstein Effect
  • Mitchel on Medicinal Mushrooms Show Promise for Treating Brain Disorders
  • BPD98 on Physicists Capture First-Ever Images of Atoms Interacting in Free Space
  • G ODonnell on Surprising Myths Shaping Our Mental Health Beliefs
Substack subscription form sign up

© 2025 ScienceBlog.com | Follow our RSS / XML feed